2017 Q1 Form 10-Q Financial Statement

#000162828017012102 Filed on December 05, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q4
Revenue $160.2M $152.1M
YoY Change 0.71% 7.35%
Cost Of Revenue $111.2M $104.1M
YoY Change 1.92% 7.3%
Gross Profit $49.07M $47.97M
YoY Change -1.78% 7.46%
Gross Profit Margin 30.62% 31.54%
Selling, General & Admin $38.70M $37.30M
YoY Change -4.44% -4.97%
% of Gross Profit 78.87% 77.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.770M $5.850M
YoY Change -0.86% 2.09%
% of Gross Profit 11.76% 12.2%
Operating Expenses $38.60M $37.30M
YoY Change -4.69% -4.97%
Operating Profit $10.40M $10.67M
YoY Change 9.73% 98.01%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $100.0K $103.0K
YoY Change 390.48%
Pretax Income $10.50M $10.77M
YoY Change 10.53% 99.15%
Income Tax $4.200M $4.353M
% Of Pretax Income 40.0% 40.42%
Net Earnings $6.305M $6.417M
YoY Change 118.54% 128.04%
Net Earnings / Revenue 3.94% 4.22%
Basic Earnings Per Share $0.22 $0.23
Diluted Earnings Per Share $0.22 $0.22
COMMON SHARES
Basic Shares Outstanding 28.48M shares
Diluted Shares Outstanding 28.53M shares

Balance Sheet

Concept 2017 Q1 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $133.8M $105.2M
YoY Change 32.49% 37.88%
Cash & Equivalents $78.99M $43.38M
Short-Term Investments $54.82M $61.82M
Other Short-Term Assets $840.0K $10.00M
YoY Change 33.97% -24.81%
Inventory $47.77M $65.02M
Prepaid Expenses
Receivables $4.000M $5.900M
Other Receivables $0.00 $0.00
Total Short-Term Assets $195.2M $186.2M
YoY Change 17.05% 12.04%
LONG-TERM ASSETS
Property, Plant & Equipment $89.22M $93.21M
YoY Change -9.9% -9.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.072M $5.414M
YoY Change 22.72% 46.21%
Total Long-Term Assets $95.29M $98.62M
YoY Change -8.35% -7.18%
TOTAL ASSETS
Total Short-Term Assets $195.2M $186.2M
Total Long-Term Assets $95.29M $98.62M
Total Assets $290.5M $284.8M
YoY Change 7.3% 4.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.58M $26.61M
YoY Change 9.75% 7.44%
Accrued Expenses $23.87M $20.45M
YoY Change 29.56% 14.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $800.0K $900.0K
YoY Change -11.11% 12.5%
Total Short-Term Liabilities $65.40M $67.40M
YoY Change 17.17% 13.28%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $200.0K
YoY Change -100.0% -81.82%
Other Long-Term Liabilities $0.00 $36.90M
YoY Change -100.0% -12.35%
Total Long-Term Liabilities $35.89M $37.10M
YoY Change -13.99% -14.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $65.40M $67.40M
Total Long-Term Liabilities $35.89M $37.10M
Total Liabilities $101.3M $104.5M
YoY Change 3.84% 1.76%
SHAREHOLDERS EQUITY
Retained Earnings $51.02M $44.72M
YoY Change 28.8% 21.75%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $189.2M $180.3M
YoY Change
Total Liabilities & Shareholders Equity $290.5M $284.8M
YoY Change 7.3% 4.54%

Cashflow Statement

Concept 2017 Q1 2016 Q4
OPERATING ACTIVITIES
Net Income $6.305M $6.417M
YoY Change 118.54% 128.04%
Depreciation, Depletion And Amortization $5.770M $5.850M
YoY Change -0.86% 2.09%
Cash From Operating Activities $28.92M $13.38M
YoY Change -5.34% 131.09%
INVESTING ACTIVITIES
Capital Expenditures -$2.260M -$4.370M
YoY Change -59.71% -27.29%
Acquisitions
YoY Change
Other Investing Activities $7.110M -$21.89M
YoY Change -135.64% 343.12%
Cash From Investing Activities $4.850M -$26.26M
YoY Change -118.97% 139.82%
FINANCING ACTIVITIES
Cash Dividend Paid $20.10M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.830M -190.0K
YoY Change -710.0% -20.83%
NET CHANGE
Cash From Operating Activities 28.92M 13.38M
Cash From Investing Activities 4.850M -26.26M
Cash From Financing Activities 1.830M -190.0K
Net Change In Cash 35.60M -13.07M
YoY Change 659.06% 142.04%
FREE CASH FLOW
Cash From Operating Activities $28.92M $13.38M
Capital Expenditures -$2.260M -$4.370M
Free Cash Flow $31.18M $17.75M
YoY Change -13.77% 50.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
59607000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7303000 USD
CY2016Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
899000 USD
CY2017Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
835000 USD
CY2017Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
155000 USD
CY2016Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
155000 USD
CY2017Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
0 USD
CY2017Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
2955000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51020000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43382000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78994000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38912000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
0 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7638000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-03
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Period End Date
DocumentPeriodEndDate
2017-10-28
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001524025
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
TILLY'S, INC.
dei Trading Symbol
TradingSymbol
TLYS
CY2017Q4 tlys Debt Instrument Covenant Minimum Eligible Inventory
DebtInstrumentCovenantMinimumEligibleInventory
50000000 USD
CY2016Q4 tlys Impaired Long Lived Assets Heldand Used Carrying Amount
ImpairedLongLivedAssetsHeldandUsedCarryingAmount
440000 USD
tlys Impaired Long Lived Assets Heldand Used Carrying Amount
ImpairedLongLivedAssetsHeldandUsedCarryingAmount
2136000 USD
CY2017Q4 tlys Impaired Long Lived Assets Heldand Used Carrying Amount
ImpairedLongLivedAssetsHeldandUsedCarryingAmount
397000 USD
tlys Impaired Long Lived Assets Heldand Used Carrying Amount
ImpairedLongLivedAssetsHeldandUsedCarryingAmount
848000 USD
CY2016Q4 tlys Impaired Long Lived Assets Heldand Used Fair Value
ImpairedLongLivedAssetsHeldandUsedFairValue
0 USD
tlys Impaired Long Lived Assets Heldand Used Fair Value
ImpairedLongLivedAssetsHeldandUsedFairValue
173000 USD
CY2017Q4 tlys Impaired Long Lived Assets Heldand Used Fair Value
ImpairedLongLivedAssetsHeldandUsedFairValue
0 USD
tlys Impaired Long Lived Assets Heldand Used Fair Value
ImpairedLongLivedAssetsHeldandUsedFairValue
0 USD
tlys Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-3911000 USD
tlys Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-4394000 USD
CY2017Q4 tlys Number Of States
NumberOfStates
31 State
CY2016Q4 tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
9 store
tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
15 store
CY2017Q4 tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
7 store
tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
10 store
CY2016Q4 tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
2 store
tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
8 store
CY2017Q4 tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
2 store
tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
4 store
tlys Percentage Of Awards Vesting On Grant Date
PercentageOfAwardsVestingOnGrantDate
0.25
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
26613000 USD
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
17584000 USD
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
27329000 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20449000 USD
CY2017Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23872000 USD
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
31854000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
57000 USD
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
66000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
96000 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
135469000 USD
CY2017Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
138102000 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
140240000 USD
us-gaap Adjustments To Additional Paid In Capital Income Tax Deficiency From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation
101000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1773000 USD
CY2016Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1631000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2131000 shares
CY2017Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1338000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1347000 shares
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1963000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
848000 USD
CY2016Q4 us-gaap Assets
Assets
284771000 USD
CY2017Q1 us-gaap Assets
Assets
290506000 USD
CY2017Q4 us-gaap Assets
Assets
292902000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
186151000 USD
CY2017Q1 us-gaap Assets Current
AssetsCurrent
195215000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
197521000 USD
CY2016Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
94000 USD
CY2017Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
107000 USD
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
161000 USD
CY2016Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
54875000 USD
CY2017Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
44892000 USD
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
59768000 USD
CY2016Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
54781000 USD
CY2017Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
44785000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
164000 USD
CY2016Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
750000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
104497000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
510000 USD
CY2017Q1 us-gaap Liabilities
Liabilities
101286000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
113772000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
284771000 USD
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
290506000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
292902000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
67402000 USD
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
65396000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
79440000 USD
CY2016Q4 us-gaap Gross Profit
GrossProfit
47969000 USD
us-gaap Gross Profit
GrossProfit
119393000 USD
CY2017Q4 us-gaap Gross Profit
GrossProfit
50094000 USD
us-gaap Gross Profit
GrossProfit
123928000 USD
CY2016Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
2005000 USD
CY2016Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
7040000 USD
CY2017Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
10031000 USD
CY2017Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
102730000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
288653000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-40082000 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6443000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5141000 USD
CY2017Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8751000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8030000 USD
CY2016Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
104137000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
289343000 USD
us-gaap Debt Instrument Covenant Description
DebtInstrumentCovenantDescription
We are required to maintain certain financial and non-financial covenants in accordance with the line of credit. The financial covenants require certain levels of leverage and profitability, such as (i) income before income taxes not to be less than $1.0 million (calculated at the end of each fiscal quarter on a trailing 12-month basis), (ii) a maximum ratio of 4.00 to 1.00 as of each quarter end for “Funded Debt to EBITDAR”, defined as the sum of total debt, capital leases and annual rent expense multiplied by six divided by the sum of net income, interest expense, taxes, depreciation, amortization and annual rent expense on a trailing 12-month basis, and (iii) requires minimum eligible inventory, cash, cash equivalents and marketable securities totaling $50.0 million as of the end of each quarter. In addition, maximum investment in fixed assets in any fiscal year of $50.0 million.
us-gaap Debt Instrument Interest Rate Terms
DebtInstrumentInterestRateTerms
The interest rate charged on borrowings is selected at our discretion at the time of draw between the London Interbank Offered Rate, plus 0.75%, or at the Bank’s prime rate.
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-298000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1194000 USD
CY2016Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
6146000 USD
CY2017Q1 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
5643000 USD
CY2017Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
5762000 USD
CY2016Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
36940000 USD
CY2017Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
35890000 USD
CY2017Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
31377000 USD
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7815000 USD
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10203000 USD
CY2017Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
23193000 USD
CY2016Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
10770000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
9203000 USD
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
8335000 USD
CY2017Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
14487000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13354000 USD
CY2016Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4353000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4097000 USD
CY2017Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5730000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5354000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3570000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4719000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10667000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9177000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2576000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
17498000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4202000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-359000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1868000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-271000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1254000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
17644000 USD
us-gaap Dividends
Dividends
20080000 USD
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5480000 USD
CY2017Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7259000 USD
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6005000 USD
CY2017Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4200000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M4D
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13659000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-6000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
14474000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1084000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
777000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
476000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-342000 USD
us-gaap Interest Paid
InterestPaid
67000 USD
us-gaap Interest Paid
InterestPaid
25000 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
65016000 USD
CY2017Q1 us-gaap Inventory Net
InventoryNet
47768000 USD
CY2017Q4 us-gaap Inventory Net
InventoryNet
62242000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-170000 USD
CY2017Q4 us-gaap Number Of Stores
NumberOfStores
220 store
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
10667000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
8933000 USD
CY2014Q1 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2020-06-26
CY2014Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
25000000 USD
CY2015Q2 us-gaap Litigation Settlement Amount
LitigationSettlementAmount
2000000 USD
CY2017Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
7500000 USD
CY2015Q2 us-gaap Loss Contingency Settlement Agreement Terms
LossContingencySettlementAgreementTerms
three years
CY2017Q4 us-gaap Line Of Credit
LineOfCredit
0 USD
us-gaap Line Of Credit Facility Covenant Compliance
LineOfCreditFacilityCovenantCompliance
we were in compliance with all of our covenants and had no outstanding borrowings under the revolving credit facility.
CY2016Q4 us-gaap Marketable Securities
MarketableSecurities
61821000 USD
CY2017Q1 us-gaap Marketable Securities
MarketableSecurities
54816000 USD
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
14112000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
12544000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5414000 USD
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6072000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7805000 USD
CY2016Q4 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
26000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
35000 USD
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
6417000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
19589000 USD
CY2017Q4 us-gaap Marketable Securities
MarketableSecurities
82800000 USD
CY2016Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
61915000 USD
CY2017Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
54923000 USD
CY2017Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
82961000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-714000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-20573000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-26513000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-37194000 USD
us-gaap Net Income Loss
NetIncomeLoss
5106000 USD
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
8757000 USD
us-gaap Net Income Loss
NetIncomeLoss
8000000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
17685000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
99000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
101000 USD
CY2017Q4 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-6000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
81762000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
30000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
112612000 USD
CY2016Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
26000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14794000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9716000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
35000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
270000 USD
CY2017Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
30000 USD
CY2016Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
103000 USD
CY2017Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
375000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
810000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
0 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
20080000 USD
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9965000 USD
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
87576000 USD
CY2017Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
3647000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
639000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
93206000 USD
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
89219000 USD
CY2016Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
5873000 USD
CY2017Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
3989000 USD
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9541000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
288000 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9759000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
70000000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
85134000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
43000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
24000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
680000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
44719000 USD
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
51023000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
38765000 USD
CY2016Q4 us-gaap Sales Revenue Net
SalesRevenueNet
152106000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
408736000 USD
CY2017Q4 us-gaap Sales Revenue Net
SalesRevenueNet
152824000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
412581000 USD
CY2016Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
37302000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
110460000 USD
CY2017Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35982000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
111384000 USD
CY2016Q4 us-gaap Share Based Compensation
ShareBasedCompensation
537000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1995000 USD
CY2017Q4 us-gaap Share Based Compensation
ShareBasedCompensation
578000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1773000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.673
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.627
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.514
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.012
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.013
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.019
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
989500 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
12.28
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
17500 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
59000 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
406000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.85
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.68
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.02
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6839000 USD
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1842375 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2133750 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.98
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.78
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
6839000 USD
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2133750 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
9.78
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.53
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
14.02
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
8.92
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.71
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1395000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y5M20D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y2M18D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
38125 shares
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
288000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
180274000 USD
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
189220000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
179130000 USD
CY2016Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
45000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
20000 shares
CY2017Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
249000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
208000 shares
CY2016Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28527000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28476000 shares
CY2017Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29031000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28954000 shares
CY2016Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28482000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28456000 shares
CY2017Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28782000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28746000 shares
us-gaap Fiscal Period
FiscalPeriod
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our fiscal year ends on the Saturday closest to January&#160;31. References to fiscal 2017 refer to the fiscal year ending February 3, 2018. References to the fiscal quarters or nine months ended </font><font style="font-family:inherit;font-size:10pt;">October&#160;28, 2017</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">October&#160;29, 2016</font><font style="font-family:inherit;font-size:10pt;">, refer to the </font><font style="font-family:inherit;font-size:10pt;">three and nine months ended</font><font style="font-family:inherit;font-size:10pt;">, respectively, as of those dates.</font></div></div>

Files In Submission

Name View Source Status
0001628280-17-012102-index-headers.html Edgar Link pending
0001628280-17-012102-index.html Edgar Link pending
0001628280-17-012102.txt Edgar Link pending
0001628280-17-012102-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
q3201710-q.htm Edgar Link pending
q32017ex311.htm Edgar Link pending
q32017ex312.htm Edgar Link pending
q32017ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlys-20171028.xml Edgar Link completed
tlys-20171028.xsd Edgar Link pending
tlys-20171028_cal.xml Edgar Link unprocessable
tlys-20171028_def.xml Edgar Link unprocessable
tlys-20171028_lab.xml Edgar Link unprocessable
tlys-20171028_pre.xml Edgar Link unprocessable